Parameter

Unit cost, USD

Price, USD

Table Column Head

Neoadjuvant

chemotherapy

Stable

Progression and hormonal chemotherapy

Progression and chemotherapy

Utility

0.89

0.85

0.74

Epirubicin (100 mg/m²), 10 mg/V

39.2

588.2

●

-

-

-

5-Fu (500 mg/m²), 250 mg/V

3.1

9.2

●

-

-

-

Cyclophosphamide (500 mg/m²), 500 mg/V

11.4

22.7

●

-

-

-

Granisetron hydrochloride (3 mg/body)

32.1

32.1

●

-

-

-

Zoledronic acid (4 mg/body), 4 mg/V

254.3

254.3

● or -*

-

-

-

Paclitaxel (80 mg/m²), 30 mg/V

66.2

264.9

●

-

-

-

Tamoxifen (20 mg/day), 20 mg/1T

4.1

4.1

-

●

●

-

Leuprorelin acetate (11.25 mg/body), 11.25 mg/1KT

605.9

605.9

-

-

●

-

Vinorelbine bitartrate (25 mg/m²), 40 mg/V

160.0

160.0

-

-

-

●

Extended-release oxycodone (40 mg/day), 20 mg/1T

4.2

8.5

-

-

-

●

Quick-release oxycodone, 5 mg

1.0

3.1

-

-

-

●

Surgery (inpatient/day)

249.8

2248.4

●

-

-

-

Radiation (50 Gy)

17.2

-

●

-

-

Hepatitis screening

35.7

●

-

-

-

Cardiac function test

91.5

●

-

-

-

CT scan with contrast medium

146.7

●

●

●

●

Contrast medium

61.2

●

●

●

●

CT scan diagnostic fee

50.9

●

●

●

●

Administration fee for chemotherapy

62.9

●

-

-

●

Biochemical test diagnostic fee

51.1

●

●

●

●

Immunology test diagnostic fee

16.8

●

●

●

●

Blood test diagnostic fee

21.7

●

●

●

●

Outpatient service fee

42.8

-

●

●

●

Prescription fee

6.3

-

●

●

●

Ultrasound test

31.7

●

●

●

●

Bone metastasis test

481.2

-

●

●

●

Total cost per annum, USD

CTZ: 5905.3 CT: 3870.9

Total cost per patient cycle (month), USD

-

438.9

1123.6

1473.1